OTC Markets OTCPK - Delayed Quote USD
Enzo Biochem, Inc. (ENZB)
0.4900
+0.0443
+(9.94%)
At close: April 24 at 3:42:25 PM EDT
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Operating Cash Flow
-14,963
-26,259
-36,976
-16,590
387
Investing Cash Flow
4,216
-545
98,980
25,223
-34,497
Financing Cash Flow
-9,177
-4,193
-1,125
-241
-242
End Cash Position
40,317
52,371
83,373
22,603
14,274
Capital Expenditure
-784
-545
-2,760
-3,472
-4,436
Issuance of Capital Stock
--
--
386
--
--
Issuance of Debt
--
--
23,846
--
--
Repayment of Debt
-3,683
-3,719
-24,982
-269
-339
Free Cash Flow
-15,747
-26,804
-39,736
-20,062
-4,049
7/31/2021 - 6/12/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NG2.SG Neogen Corp
4.5400
-1.30%
ACRS Aclaris Therapeutics, Inc.
1.2700
+6.72%
PRPH ProPhase Labs, Inc.
0.3352
-5.10%
PRPO Precipio, Inc.
6.73
-12.60%
NEOG Neogen Corporation
5.20
+5.69%
OPK OPKO Health, Inc.
1.4600
-0.68%
WGS GeneDx Holdings Corp.
109.39
+3.50%
DHR Danaher Corporation
196.50
+0.10%
TMO Thermo Fisher Scientific Inc.
426.66
-1.15%